Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Cresanto Global Limited

CRESANTO
BSE
4.65
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Cresanto Global Limited

CRESANTO
BSE
4.65
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2Cr
Close
Close Price
4.65
Industry
Industry
Packaging - Others
PE
Price To Earnings
PS
Price To Sales
39.74
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
-64.71%
Peer Comparison
How does CRESANTO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
CRESANTO
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-20.0
Other Income
Other IncomeCr
000000001000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-100.060.00.00.037.50.00.0-1,150.0240.0-350.050.064.0
NPM
NPM%
-20.0
EPS
EPS
-0.20.00.0-0.1-0.10.00.0-0.60.2-0.20.0-0.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
000000000000
Growth
Revenue Growth%
Expenses
ExpensesCr
000000000011
Operating Profit
Operating ProfitCr
0000000000-1-1
OPM
OPM%
-1,080.0
Other Income
Other IncomeCr
000000000011
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth
PAT Growth%
62.9-105.4-33.0-13.35.5-4.0-23.6-19.2-108.340.6-77.733.5
NPM
NPM%
-240.0
EPS
EPS
0.0-0.1-0.1-0.1-0.1-0.1-0.20.0-0.4-0.2-0.4-0.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
-6-6-6-6-6-6-6-6-7-7-7-7
Current Liabilities
Current LiabilitiesCr
222222200000
Non Current Liabilities
Non Current LiabilitiesCr
000000022222
Total Liabilities
Total LiabilitiesCr
000000000000
Current Assets
Current AssetsCr
000000000000
Non Current Assets
Non Current AssetsCr
000000000000
Total Assets
Total AssetsCr
000000000000

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0000000-2000
Investing Cash Flow
Investing Cash FlowCr
00000002001
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
0000000-2000
CFO To PAT
CFO To PAT%
166.1-14.3-0.2-0.5-2.10.5-0.52,689.195.859.7262.9
CFO To EBITDA
CFO To EBITDA%
76.1-21.2-0.3-0.8-3.80.4-0.42,870.088.162.780.8

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
21111001111
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.00.00.00.0
Price To Sales
Price To Sales
Price To Book
Price To Book
-1.0-0.8-0.6-0.5-0.5-0.2-0.2-0.3-0.4-0.4-0.5
EV To EBITDA
EV To EBITDA
-93.8-131.5-98.0-90.1-100.0-39.4-37.6-9.4-4.7-34.7-6.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
NPM
NPM%
ROCE
ROCE%
-6.9-17.2-23.7-34.7-44.6-65.2-42.93.97.4-421.630.3
ROE
ROE%
1.12.12.83.02.82.83.43.87.44.27.0
ROA
ROA%
-6.0-13.4-18.1-21.0-20.2-21.7-27.4-33.3-109.9-67.4-578.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Cresanto Global Limited is an Indian listed entity currently undergoing a foundational **strategic pivot** and **capital restructuring**. Following a change in ownership and management in early **2025**, the company is transitioning from a dormant pharmaceutical-focused business into a specialized **packaging and trading** enterprise. The company is currently executing a "clean-slate" strategy to address historical losses and position itself within the high-growth global flexible packaging market. --- ### **Strategic Pivot: From Pharmaceuticals to Flexible Packaging** Following the approval of a new **Object Clause** in **May 2025**, the company has abandoned its legacy pharmaceutical mandate to focus on the manufacturing, trading, and distribution of packaging materials. * **Core Business Activities:** * **Manufacturing & Processing:** Production of packaging solutions using **paper, plastic, foils, and man-made fibers**. * **Specialized Packaging:** Development of cardboard, corrugated, pillow, and polythene packing, as well as industrial containers and hollow wares. * **Value-Added Services:** Specialized decoration and printing on paper sheets for food, commercial, and industrial applications. * **Trading & Distribution:** Acting as a broker, importer, and exporter for **FMCG products**, plastic goods, and industrial spares. * **Operational Philosophy:** The new model emphasizes a "customer-first" approach, integrating supply-chain reliability with a commitment to **eco-friendly materials** and sustainable trading practices. --- ### **Corporate Restructuring & New Management Control** The company concluded a management takeover via an **Open Offer** in early **2025**, bringing in a new promoter group with a mandate for revitalization. | Feature | Details | | :--- | :--- | | **New Promoter Group** | Nishant Nathmal Bajaj, Prashant Nathmal Bajaj, Hitesh Bajoria, Tushar Pandit Awante, and Urmila Hansraj Sharma | | **Acquisition Stake (SPA)** | **12,12,050 shares (28.36%)** acquired from the erstwhile promoter | | **Open Offer Details** | **11,11,110 shares (26%)** at **₹3.00 per share**; Total consideration **₹33.33 Lakhs** | | **Post-Transaction Holding** | Up to **58.27%** of Voting Share Capital (assuming full acceptance) | | **Key Leadership** | **Mr. Prashant Bajaj** appointed as **Managing Director & CFO** (5-year term) | | **Board Composition** | **6 Directors** (1 Executive, 2 Independent, 3 Non-Executive) | To align with this new identity, the company rebranded from **Raymed Labs Limited** to **Cresanto Global Limited** in **April 2025** and is relocating its registered office from **Uttar Pradesh** to **Mumbai, Maharashtra** to enhance operational efficiency. --- ### **Financial Reconstruction & Capital Reduction Scheme** As of **March 31, 2025**, the company reported a turnaround in activity with revenue of **₹52.59 Lakhs**, a significant improvement over the zero-revenue status of **FY 2023-24**. However, to address **accumulated losses of ₹6.86 Crores**, the Board has approved a drastic **90% Capital Reduction**. #### **Capital Reduction Table** | Particulars | Pre-Reduction | Post-Reduction | Net Change | | :--- | :--- | :--- | :--- | | **Equity Share Capital** | **₹4,27,35,000** | **₹42,73,500** | **(₹3,84,61,500)** | | **Total Equity Shares** | **4,273,500** | **427,350** | **(3,846,150)** | | **Face Value per Share** | **₹10** | **₹10** | - | | **Accumulated Losses** | **(₹6,86,14,000)** | **(₹3,01,52,500)** | **₹3,84,61,500** | * **Rationale:** The reduction writes off **₹3.84 Crores** in losses against paid-up capital. This "leaner" balance sheet is intended to reflect actual asset values and enable future dividend payments and fund-raising. * **Liquidity & Debt:** Total borrowings stand at **₹237.12 Lakhs**, all with a maturity of **1 to 5 years**. The company has not accepted public deposits. --- ### **Market Opportunity: The Flexible Packaging Sector** Cresanto Global is entering a market projected to grow at a **CAGR of 5.8%** through **2034**. * **Growth Drivers:** * Surging demand for lightweight, cost-effective packaging in the **FMCG** and **Food & Beverage** sectors. * The expansion of **e-commerce** requiring durable, specialized shipping materials. * A global shift toward **recyclable and sustainable materials** to meet ESG mandates. * **Competitive Landscape:** While the company pivots away from the pharmaceutical supply chain (where India holds a **20% global share**), it faces high pricing pressure from established packaging giants and volatility in raw material costs (plastics, films, and aluminum). --- ### **Listing Data & Shareholding Structure** The company is listed on the **BSE** (Scrip Code: **531207**; Scrip ID: **RAYLA**). | Category | Status / Value | | :--- | :--- | | **Trading Status** | Classified as **infrequently traded**; currently **suspended** due to past fee arrears | | **Dematerialization** | **78.838%** (NSDL: 59.342%, CDSL: 19.496%) | | **Physical Shares** | **21.162%** | | **Listing Fees** | Outstanding interest dues of **₹1,62,250** for FY 2023-24 | --- ### **Critical Risk Factors & Auditor Concerns** Investors should note several high-priority risks associated with this transition: * **Going Concern Uncertainty:** Auditors have issued an **Emphasis of Matter** noting that the company’s net worth was substantially eroded and current liabilities exceeded current assets. Historically, administrative expenses were funded personally by a former Director due to a **paucity of funds**. * **Transition Risk:** The company is moving from a period of **three years of total inactivity** into a highly competitive, capital-intensive packaging industry. * **Regulatory Compliance:** The company has historically struggled with compliance, including the failure to appoint a **Whole Time Company Secretary** and delays in paying **Annual Listing Fees (ALF)** to the BSE. * **Execution Risk:** The success of the pivot depends entirely on the new management's ability to deploy the **₹33.33 Lakh** escrow funds effectively and secure new contracts in the packaging space. * **Asset Realizability:** While management claims **Current Assets and Loans** are realizable, historical debtor balances of **₹8.51 Lakh** were recently written off, indicating potential legacy asset quality issues.